On March 23, Auris Health, Inc. announced FDA clearance for the Monarch Platform, Auris’ new system for robotic endoscopy. According to Auris Health, the Monarch Platform “integrates the latest ...
Auris Health Unveils the FDA-Cleared Monarch Platform, Ushering in a New Era of Medical Intervention
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Auris Health, Inc. ("Auris Health"), formerly known as Auris Surgical Robotics, Inc., today announced U.S. Food and Drug Administration (FDA) clearance of the ...
DALLAS, May 20, 2019 /PRNewswire/ -- Auris Health, Inc., part of Johnson & Johnson Medical Devices Companies,* today announced early positive results from an ongoing study designed to evaluate the ...
The New Jersey-based healthcare conglomerate also acquired Auris' Monarch robotic platform and the pair were developed to diagnose and treat lung cancer. The judge said that rather than dedicating ...
REDWOOD CITY, Calif., Jan. 21, 2021 /PRNewswire/ -- Auris Health, Inc., a subsidiary of Ethicon, Inc., part of the Johnson & Johnson Medical Devices Companies*, today announced results from the ...
Auris Health (née Auris Surgical Robots) has done a pretty good job flying under the radar, in spite of raising a massive amount of capital and listing one of the key people behind the da Vinci ...
Johnson & Johnson’s Auris Health revealed late-breaking data from the BENEFIT study during the CHEST 2019 Conference in New Orleans last week. BENEFIT is a study of the Monarch Platform, a robotic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results